Skip to main content
    V

    Verastem Inc (VSTM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.41
    -0.29 (-3.77%)

    Market Cap: $970.31M

    Last updated: Nov 17, 2026 at 4:35 PM ET

    Verastem Inc (VSTM) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Verastem (VSTM) trades at 7.5x sales and 74.3x book value. Its P/S of 7.5x is below its 5-year median of 37.9x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/EN/A
    Price to sales7.5x
    Price to book74.3x
    PEGN/A
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/B is 1963.9% above 3.6x.

    MultipleCurrent5-year median10-year median
    P/S7.5x37.9xN/A
    P/B74.3x4.2x3.6x
    Medians of month-end values through Oct 2026: 49 to 51 months (5-year) and 111 months (10-year).

    Valuation History

    Over the 7 of the 10 year ends shown that have a P/S, its P/S ranged from 3.9x in 2020 to 179.7x in 2021.

    Year endPriceP/SP/B
    2025$7.7219.5x11.3x
    2024$5.1747.1xN/A
    2023$8.14N/A3.8x
    2022$4.8315.1x1.7x
    2021$24.61179.7x4.3x
    2020$25.573.9x3.1x
    2019$16.095.7x14.3x
    2018$40.349.0x2.3x
    2017$36.85N/A2.2x
    2016$13.45N/A0.6x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    Frequently Asked Questions About VSTM

    What is VSTM's price to sales ratio?

    Verastem has a price to sales ratio of 7.5x.